Lifecore Biomedical Inc LFCR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update
-
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
-
Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024
-
Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology
-
LFCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lifecore Biomedical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
LFCR DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCR
-
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR)
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.54
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 524
- Website
- https://www.lifecore.com
Comparables
Valuation
|
Metric
|
LFCR
|
688658
|
603896
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 162.74 | 20.69 |
Price/Book Value | — | 2.56 | 2.25 |
Price/Sales | 1.54 | 2.34 | 6.33 |
Price/Cash Flow | — | 24.94 | 13.42 |
Price/Earnings
LFCR
688658
603896
Financial Strength
|
Metric
|
LFCR
|
688658
|
603896
|
|---|---|---|---|
Quick Ratio | 0.76 | 1.35 | 3.21 |
Current Ratio | 1.83 | 1.82 | 3.70 |
Interest Coverage | 1.30 | 6.92 | 16.62 |
Quick Ratio
LFCR
688658
603896
Profitability
|
Metric
|
LFCR
|
688658
|
603896
|
|---|---|---|---|
Return on Assets (Normalized) | −10.04% | 0.83% | 7.55% |
Return on Equity (Normalized) | −962.48% | 1.36% | 11.00% |
Return on Invested Capital (Normalized) | −4.34% | 1.16% | 7.10% |
Return on Assets
LFCR
688658
603896
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Sdrzljpbq | Rsfp | $86.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Tyynkyjmg | Fkctps | $74.3 Bil | |||
| Haleon PLC ADR
HLN
| Xbrbtvrm | Pfcc | $45.9 Bil | |||
| Viatris Inc
VTRS
| Qjgxwgvhq | Hcy | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Pbfkbkj | Pflx | $13.2 Bil | |||
| Catalent Inc
CTLT
| Rkxkxjp | Nxznh | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Tsdnhrj | Flbqyn | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Lxggmwfmm | Yybj | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Gsxydtvgj | Hwtl | $2.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Tbxhzbkw | Dct | $2.2 Bil |
United States